Liquidia Corporation (LQDA)
Market: NASD |
Currency: USD
Address: 419 Davis Drive
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Show more
📈 Liquidia Corporation Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$30.80
-
Upside/Downside from Analyst Target:
125.81%
-
Broker Call:
16
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
0-10%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
<0%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Liquidia Corporation
| Date | Reported EPS |
|---|
| 2026-05-06 (estimated upcoming) | - |
| 2026-03-17 (estimated upcoming) | - |
| 2025-11-11 (estimated upcoming) | - |
| 2025-11-10 (estimated upcoming) | - |
| 2025-08-05 (estimated upcoming) | - |
| 2025-08-04 (estimated upcoming) | - |
| 2025-05-12 | - |
| 2025-05-11 | - |
| 2025-05-08 | - |
| 2025-05-08 | -0.45 |
| 2025-03-19 | -0.46 |
| 2025-03-10 | - |
| 2024-11-13 | -0.3 |
| 2024-08-07 | -0.37 |
| 2024-08-06 | -0.37 |
| 2024-05-13 | -0.54 |
| 2024-05-12 | -0.54 |
| 2024-03-13 | -0.42 |
| 2024-03-12 | -0.42 |
| 2023-11-07 | -0.24 |
| 2023-11-06 | -0.24 |
| 2023-08-10 | -0.36 |
| 2023-08-09 | -0.36 |
| 2023-05-04 | -0.18 |
| 2023-05-03 | -0.18 |
| 2023-03-16 | -0.09 |
| 2023-03-15 | -0.09 |
| 2022-11-08 | -0.14 |
| 2022-11-07 | -0.14 |
| 2022-08-11 | -0.15 |
| 2022-08-10 | -0.15 |
| 2022-05-12 | -0.3 |
| 2022-05-11 | -0.3 |
| 2022-03-17 | -0.23 |
| 2022-03-16 | -0.23 |
| 2021-11-03 | -0.14 |
| 2021-11-02 | -0.14 |
| 2021-08-10 | -0.13 |
| 2021-08-09 | -0.13 |
| 2021-05-13 | -0.21 |
| 2021-05-12 | -0.21 |
| 2021-03-23 | -0.38 |
| 2021-03-22 | -0.38 |
| 2020-11-06 | -0.4 |
| 2020-11-05 | -0.4 |
| 2020-08-10 | -0.49 |
| 2020-08-09 | -0.49 |
| 2020-05-11 | -0.52 |
| 2020-05-10 | -0.52 |
| 2020-03-11 | -0.71 |
| 2020-03-10 | -0.71 |
| 2019-11-12 | -0.72 |
| 2019-08-07 | -0.32 |
| 2019-05-01 | -0.87 |
| 2019-02-25 | -0.62 |
| 2018-10-30 | -0.83 |
| 2018-08-13 | - |
| 2018-07-25 | - |
📰 Related News & Research
No related articles found for "liquidia corporation".
